Loading clinical trials...

Sinonasal Risk Factors for Occurrence of Unilateral Versus Bilateral Allergic Fungal Rhinosinusitis . | Clinical Trials | Clareo Health

Back to clinical trial search

Not Yet RecruitingNCT06376071

Sinonasal Risk Factors for Occurrence of Unilateral Versus Bilateral Allergic Fungal Rhinosinusitis .

This study aims to assess Sinonasal risk factors for occurrence of unilateral versus bilateral allergic fungal rhino sinusitis regarding:: 1. anatomical variations and correlate radiological finding ...

Lead sponsor: Assiut University•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

khater nosir sayed, master

CONTACT

01011973180 [email protected]

Related studies

COMPLETEDPhase 3

Dupilumab in Allergic Fungal Rhinosinusitis (AFRS) (LIBERTY-AFRS-AI)

NCT04684524 · Allergic Fungal Rhinosinusitis

WITHDRAWNPhase 3

Study of Dupilumab 300 mg Every Other Week After Endoscopic Sinus Surgery in Patients With Allergic Fungal Rhinosinusitis (AFRS) on a Background Therapy With Intranasal Corticosteroid Spray

NCT06461949 · Allergic Fungal Rhinosinusitis (AFRS), Chronic Rhinosinusitis (CRS), and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 19, 2024Terms

Trial snapshot

StatusNOT_YET_RECRUITING

Phase—

Enrollment76

Start dateMay 2024

Last updatedApr 19, 2024

Condition

Allergic Fungal Rhinosinusitis

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 19, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions